Nordic Precision Medicine Forum 28-29 April 2022 Stockholm
Nordic Precision Medicine returned to Stockholm after a hiatus due to COVID-19.
Just prior to the pandemic Sweden launched its first ever national Life Science Strategy in eight priority areas covering the strengthening of academic research, facilitating collaboration between academia and industry, attracting more industry initiated clinical trials, and the continuous skills development needed for precision medicine and highly advanced production of pharmaceuticals and medtech devices. Across the Nordic countries precision medicine and technology developments continue at pace, truly putting them in a favourable position when it comes to taking on the opportunities and challenges of implementing precision medicine, with its promise to really transform future healthcare as well as the entire life science sector.
Since 2016 we have convened the regions leading scientists, healthcare practitioners, and industry pioneers at our annual meeting. In 2022 there was a whole lot more interaction as we finally got back to in-person events.
We enjoyed seeing you in Stockholm and look forward to meeting up again in 2023!
Agenda (PDF)
Open the agenda for Nordic PMF as a PDF in a separate tab.

#nordicpmf Share the news
Nordic 2022 Speakers
Nils J. Færgeman
Nils J. Færgeman, Professor and Director of the molecular metabolism and metabolomics unit at the University of Southern Denmark
Tuuli Lappalainen, PhD
Tuuli Lappalainen, PhD, Professor at KTH Royal Institute of Technology.
Frida Lundmark
Frida Lundmark joined Lif in 2020 as an expert within Life Science, research and innovation
Sebastian Schwarz
Sebastian graduated from HEC Paris and Ecole polytechnique with a double degree in Data Science for Business.
Dr Cristina Legido-Quigley
Head of Systems Medicine at Steno Diabetes Center Copenhagen and an Associate Professor at King’s College London.
Bettina Lundgren CEO, M.D., D.M.Sc.
CEO of Danish National Genome Center. Danish National Genome Center was established 1st of May 2019.
Hege G. Russnes, MD, PhD
Head, Section for experimental pathology and Research Support, Dept. of Pathology, Oslo University Hospital, Norway
Agneta Larhed, PhD
Agneta Larhed, PhD, senior pharmaceutical consultant, OnDosis, Mölndal, Sweden and RegSmart, Uppsala, Sweden
Prof. Neeme Tõnisson
Neeme Tõnisson is a Professor of Clinical Genetics and group leader in the Institute of Genomics, Univ. of Tartu / Estonian Biobank
Mattias Paulsson, PhD
Mattias Paulsson, PhD, Deputy chief pharmacist, Uppsala University Hospital, Sweden
Maj-Britt Juhl Poulsen
Executive Advisor, PhD Danish Regions, Ph.D. in Science and Technology Studies and a Master Degree of Biochemistry.
Stephen A. Williams
Steve Williams is currently responsible for Clinical R&D, Medical Affairs and Regulatory and Quality.
Dr Bettina Ryll
Bettina Ryll, MD/PhD works as subject expert for personalised medicine for Vision Zero Cancer
Mattias Rantalainen, Associate Professor, PhD
Mattias Rantalainen leads the Predictive Medicine group at Department of Medical Epidemiology and Biostatistics at Karolinska Institute in Sweden.
Carolina Donnerin
Carolina Donnerin is an innovation and project manager at RISE. Her background includes international experience of healthcare transformation and digital innovation.
Asif Jan
Asif Jan joined Owkin from Roche where he was Global Head of Analytics (Personalised Healthcare) in the Pharma Product Development division.
Maria Pernemalm
Maria Pernemalm, Assistant Professor, Department of Oncology and Pathology at Karolinska Institutet
Thorben Seeger
Thorben Seeger is the mastermind behind Lifebit’s international commercial operations.
Annika Ahlford, PhD
Annika has been with Devyser since 2015, first as Technical Lead at R&D department and since June 2021 as Product Manager
Per B. Andersen
Per B. Andersen, based in Copenhagen has 15 years of experience with Diagnostic testing pathways and assays.
Leon du Toit
Leon du Toit has over 10 years’ experience in developing IT solutions. Speaker at P{recision Medicine Forum 2022
Malin Eklund, PhD
Malin Eklund has a PhD in biotechnology from the Royal Institute of Technology, KTH in Stockholm Sweden.
Åslaug Helland
Oncologist, Oslo University Hospital, Head of Research, Oslo Comprehensive Cancer Center, OUS, Professor University of Oslo, Norway
Per-Johan Jakobsson
Per-Johan Jakobsson, Consultant Rheumatologist and Professor in Translational Inflammation Research
Prof. Dr. Janne Lehtiö
Since 2015 Janne Lehtiö has held the faculty professor position in Medical Proteomics at Karolinska Institutet, Stockholm, Sweden
Ebba Hallersjö Hult
Ebba Hallersjö Hult, Co-founder and Head of the Innovation Milieus Vision Zero Cancer
Matej Orešič PhD
PhD in Biophysics from Cornell University. Professor of Medicine with Specialization in Systems Medicine at Örebro University
Mathieu Andreux
Mathieu completed his training with a PhD in Deep Learning and Signal Processing at PSL university and ENS Paris.
Tobias Sjöblom
Tobias Sjöblom, Professor in Tumor Genetics at Uppsala University, Sweden.
Zsolt Illes MD
Zsolt Illes MD, PhD is a professor at the University of Southern Denmark (Institute of Clinical Research, BRIDGE and Institute of Molecular Medicine).
Cindy Lawley
Cindy is Global Director of Population Health (Olink), speaker at Nordic PMF 2022.
Judith Kairies
Judith Kairies is experienced within regulatory affairs and quality assurance in the life science industry.
Grethe S. Foss
Grethe S. Foss is Senior Adviser and Project Leader for personalised medicine at the Norwegian Directorate of Health.
Merike Leego, MBA, MSc
Merike Leego, MBA, MSc, is Innovation Manager at EIT Health Scandinavia, the European Commission funded network.
Katarina Nyström
Legal counsel at Sahlgrenska University Hospital since 2015. In 2020 she started to work for Genomic Medicine Sweden
Mohsen Shadidi
Mohsen Shadidi, Head of Section for Molecular Pathology, Department of Pathology, Oslo University Hospital
Peter Asplund
Peter is Co-founder and Project Director MEGALIT. Director Department of Anestethic and Intensive Care, Region Örebro Län, Örebro, Sweden
Thorunn Rafnar
Thorunn Rafnar is the Head of Oncology at Reykjavik-based deCODE genetics. She received a Ph.D. degree at the University of North Carolina in 1990
Anna Wedell, MD, PhD
Anna Wedell, MD, PhD, Professor at Karolinska Institutet and Senior Consultant at the Centre for Inherited Metabolic Diseases
Päivi Östling
Päivi Östling has more than 10 years of research experience in the field of precision cancer medicine (PCM) research.
Professor Dame Sue Hill
Professor Dame Sue Hill is the Chief Scientific Officer for England. Sue works across the health …
Seppo Vainio
Seppo Vainio is a professor of developmental biology at the University of Oulu, Finland.
Chris Wigley
Chris Wigley is the CEO of Genomics England, which exists to push insights from cutting edge genomics data analytics into routine medical care.
Dr Jutta Heix
Head of International Affairs at Oslo Cancer Cluster, is a life science professional with more than 20 years of industry experience.
Patrik Georgii-Hemming
Patrik Georgii-Hemming is Chief Medical Information Officer at Karolinska University Hospital.
Joni Komulainen
Senior Ministerial Advisor, Ministry of Social Affairs and Health, Finland
Bengt Persson
Professor of bioinformatics at Uppsala University, Director of NBIS (National Bioinformatics Infrastructure Sweden, the SciLifeLab Bioinformatics platform)
Kári Stefánsson, M.D.
Kári Stefánsson, M.D., Dr. Med. is founder and CEO of Reykjavik-based deCODE genetics. In Iceland
Per Wessman, Ph D
Dr Wessman holds a position as Principal Scientist in product development and formulation.
Richard Rosenquist Brandell
Professor of Clinical Genetics at Karolinska Institutet, and Senior Physician at Karolinska University Hospital.
Anagha Joshi
Anagha Joshi is a Professor in Bioinformatics at the faculty of medicine at the University of Bergen since 2018.
Nick Baker
Nick has over 20 years experience in regulatory affairs for IVD’s first at the British Standards Institute and then at Lloyd’s Register Quality Assurance (LRQA)
Prof. Andres Metspalu
Prof. Andres Metspalu, Head of the Estonian Biobank, Institute of Genomics, University of Tartu.
Henrik Eriksson
Is involved in Genome Medicine Sweden projektet i AP2 Infrastruktur & informatic.
Dr. Léon van Kempen
Dr. Léon van Kempen is a Clinical Scientist in Molecular Pathology at the department of Pathology, University Medical Center Groningen,
Kjetil Taskén M.D., Ph.D.
Professor of Medicine at University of Oslo in 2001 and since 2018 served as Head of the Institute of Cancer Research, Oslo University Hospital
Prof. Kristian Hveem
Kristian Hveem,Professor in Medicine and Clinical Epidemiology at the Faculty of Medicine and Health Sciences, at the NTNU
Anna Martling
Anna Martling is a Professor of Surgery at Karolinska Institutet, Stockholm, Sweden.
Sponsorship Opportunities
Nordic Precision Medicine Forum offers a unique environment to make new connections, share ideas and formulate partnerships for future collaboration. We work closely with our sponsors to ensure that your objectives are met by building bespoke marketing solutions. So be it a plenary speaking slot, hosting a roundtable or exhibiting at our forum, we ensure you are in front of the right audience.